Counselors helping people use the federal government's online health exchange are giving mixed reviews to the updated site, with some zipping through the application process while others are facing the same old sputters and even crashes. The Obama administration had promised a vastly improved shopping experience on healthcare.gov by the end of November, and this is the first week for users to test the updated site.
A government panel proposed additional measures to lessen the radioactive water crisis at Japan'...
The Office of Naval Research is demonstrating the...
Biogen Idec said Monday the U.S. Food and Drug Administration (FDA) extended its review of Alprolix, a drug designed to treat hemophilia B. Biogen Idec said the FDA extended its review by three months. The move came after the agency asked Biogen for more information about validation of part of the Alprolix manufacturing process.
Bruker Corp. has announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. The clearance marks progress in Bruker’s efforts to develop MALDI-TOF mass spectrometry into the most advanced platform for clinical microbiology identification.
Damage to or theft of technical equipment represents a dramatic financial and scientific loss to researchers. Scientists in Germany decided to find out whether the information content and tone of labels attached to the equipment could reduce the incidence of vandalism. They found that a friendly, personal label reduced the interaction of people with the equipment in comparison with neutral or threatening labels.
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits. In a warning letter posted online Monday, FDA regulators say that the Silicon Valley company has not shown that its tests are safe or effective despite "more than 14 face-to-face and teleconference meetings" and "hundreds of email exchanges."
According to a recent study, fashions in research funding, reward structures in universities and streamlining of scientific agendas undermine traditional academic norms and may result in science bubbles. New research shows how the mechanisms that set off the financial crisis might be replicating in the field of science.
The scientist credited with inventing the World Wide Web, Tim Berners-Lee, says a growing tide of surveillance is threatening democracy's future. Lee, a former R&D Magazine Scientist of the Year said Friday that as more people use the Internet and social media to "expose wrongdoing," some governments are feeling threatened.
Colorado's proposal to curb air pollutants from oil and gas operations got praise from industry representatives and environmental activists Thursday at its first hearing. But both sides warned the Colorado Air Quality Control Commission that there will still be haggling over the particulars of three rule changes introduced this week.
The U.S. Naval Research Laboratory (NRL)'s Acoustics Div., with Bluefin Robotics, executed a record setting 507 km (315 mile), long-endurance autonomy research mission using its heavyweight-class mine countermeasures autonomous underwater vehicle (AUV), Reliant. NRL's Reliant AUV, when equipped with a low-frequency broadband sonar system, is perhaps best known as the prototype for the new U.S. Navy Knifefish mine-hunter.
With two days left at the U.N. climate talks in Warsaw, there was commotion Wednesday after negotiators for developing nations said they walked out of a late-night meeting on compensation for the impact of global warming. Rich and poor nations are struggling with a yawning rift as developing countries look for new ways to make developed countries accept responsibility for global warming and pay for it.
Within the pharmaceutical industry, the rapid identification, elucidation and characterization of synthetic, process impurities and degradation products is an intense and comprehensive undertaking. In the development of a formulated drug substance, the U.S. Food and Drug Administration (FDA) requires that all impurities introduced in the proposed process above 0.1% must be isolated and fully characterized.
Leaders in the petascale computing arena in the U.S. and Japan have signed a memorandum of understanding (MOU) establishing a cooperative relationship in support of projects aimed at expanding the use of petascale computing in the scientific and engineering communities. The MOU was signed at SC13.
Workers started removing radioactive fuel rods Monday from a reactor building at the crippled Fukushima Dai-Ichi nuclear power plant, Tokyo Electric Power Co. said. The painstaking and risky task is a crucial first step toward a full cleanup of the earthquake and tsunami-damaged plant in northeastern Japan.
Activists taking part in U.N. climate talks say Japan's decision to drastically scale back its target for reducing greenhouse gas emissions will hurt the battle against global warming. The new target approved by the Japanese Cabinet calls for reducing emissions by 3.8% from their 2005 level by 2020.
Google has become less likely to comply with government demands for its users' online communications and other activities as authorities in the U.S. and other countries become more aggressive about mining the Internet for personal data. Legal requests from governments for people’s data have risen 21% from the last half of last year.
The U.S. Food and Drug Administration has approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer. The agency says it approved Imbruvica for patients with mantle cell lymphoma who have already received at least one previous drug therapy.
The widespread use of advanced surveillance technologies by state and local police departments will improve the efficiency of criminal investigations. But a lack of oversight and regulation poses significant privacy concerns, warns Stephen Rushin, a professor of law at the Univ. of Illinois.
When Iran appeared close to a preliminary deal with world powers over its nuclear program, France stepped up to say: Not so fast — a surprise move that exposed divisions among the United States and other Western negotiators who had long been in lockstep on the issue.
A new study shows that the reduction of pollution emissions from power plants in the mid-Atlantic is making an impact on the quality of the water that ends up in the Chesapeake Bay. The study confirms a decreased amount of emissions of nitrogen oxide from coal-fired power plants.
According to a study published by scientists at the Potsdam Institute for Climate Impact Research, the strategy of assigning a price to global carbon nanotubes emissions could generate a revenue of $32 trillion over the 21st century, exceeding by far the $12 trillion of lost profits from fossil fuel owners.
The Ukrainian government signed a shale gas production-sharing agreement with the Chevron, as the country strives for energy independence from neighboring Russia. Energy Minister Eduard Stavitsky said that under the deal, Chevron will initially invest $350 million into exploratory and drilling work in the Oleska field in western Ukraine. Total investment could surpass $10 billion over 50 years.
Slapping a 20% tax on soda in Britain could cut the number of obese adults by about 180,000, according to a new study. Though the number works out to a modest drop of 1.3% in obesity, scientists say that reduction would still be worthwhile in the U.K., which has a population of about 63 million and is the fattest country in Western Europe. About one in four Britons is obese.
New research from North Carolina State Univ. and the Univ. of Minnesota finds that people in the U.S. want labels on food products that use nanotechnology—whether the nanotechnology is in the food or is used in food packaging. The research also shows that many people are willing to pay more for the labeling.
The U.S. Food and Drug Administration has approved a stronger, single-ingredient version hydrocodone, the widely abused prescription painkiller. The agency said it approved the extended-release pill Zohydro ER for patients with pain that requires "daily, around-the-clock, long-term treatment" that cannot be treated with other drugs.
The U.S. Food and Drug Administration has issued a positive review for a highly anticipated hepatitis C drug from Gilead Sciences, saying the pill cures more patients in less time than currently available treatments. The agency posted its review of Gilead's sofosbuvir online ahead of a meeting Friday where government experts will vote on whether to recommend the drug's approval.
European Union lawmakers on Monday adopted sweeping new data protection rules to strengthen online privacy, and sought to outlaw most data transfers to other countries' authorities to prevent spying. The draft regulation was beefed up after Edward Snowden's leaks about allegedly widespread U.S. online snooping, and the legislation is poised to have significant implications for U.S. Internet companies.
- Page 1